Castle Biosciences Reports Second Quarter 2024 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. DAL
9. TMUS
10. VZ

Go back to Castle Biosciences Reports Second Quarter 2024 Results

Castle Biosciences (CSTL) PT Raised to $35 at BTIG

August 6, 2024 7:31 AM EDT

BTIG analyst Sung Ji Nam raised the price target on Castle Biosciences (NASDAQ: CSTL) to $35.00 (from $32.00) while maintaining a Buy rating.

The analyst comments "Shares of CSTL are up 12% in the pre-market following a strong 25% Q2 revenue beat and raise to its... More

Castle Biosciences Inc. (CSTL) Tops Q2 EPS by 58c, Beats on Revenue; Offers FY24 Revenue Guidance

August 5, 2024 4:20 PM EDT

Castle Biosciences Inc. (NASDAQ: CSTL) reported Q2 EPS of $0.31, $0.58 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $87 million versus the consensus estimate of $69.37 million.

GUIDANCE:

Castle Biosciences Inc. sees FY2024 revenue of $275-300 million, versus the... More